| NDC Code | 0409-0217-01 |
|---|
| Package Description | 25 VIAL, PATENT DELIVERY SYSTEM in 1 CARTON (0409-0217-01) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, PATENT DELIVERY SYSTEM (0409-0217-11) |
|---|
| Product NDC | 0409-0217 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Maxipime |
|---|
| Non-Proprietary Name | Cefepime |
|---|
| Dosage Form | INJECTION, POWDER, FOR SOLUTION |
|---|
| Usage | INTRAVENOUS |
|---|
| Start Marketing Date | 20130218 |
|---|
| End Marketing Date | 20191231 |
|---|
| Marketing Category Name | NDA |
|---|
| Application Number | NDA050679 |
|---|
| Manufacturer | Hospira, Inc. |
|---|
| Substance Name | CEFEPIME HYDROCHLORIDE |
|---|
| Strength | 1 |
|---|
| Strength Unit | g/1 |
|---|
| Pharmacy Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [CS] |
|---|